Skip to content

PCBL Chemical Limited (PCBL)

Large Cap

Chemicals stocks · Large cap · NSE

PCBL Chemical Limited manufactures carbon black, a key ingredient for the tyre and non-tyre industries, and operates a specialty chemicals business (Aquapharm) focusing on water solutions, home care, and oil & gas. The company is also diversifying into battery chemicals through its Nanovace platform.

₹302.75
-6.55 · -2.12%
Market cap ₹11,912 Cr
IndicesNifty 500
Data qualityFresh enough for analysisQuote updated 19 Oct, 03:31 pm IST
Details
Quote19 Oct, 03:31 pm IST
Base fundamentals20 Oct 2026 · screener
Latest result29 Jul, 07:54 pm IST
Score20 Oct, 05:15 am IST · v4.3-runtime-valuation
Tags15 Aug 2026
Coverage14/14 · 100%
Valuation2026-07-20 · Rf 6.8% · Chemicals P/E 33.1 (n=45)
Technical timing lens

Trend score and candlestick chart

50Neutral

MACD − · sector -4.2pp vs Nifty 500 (3M)

Stock trend: 53
Sector RS: 46
Sector 3M: -9.8% vs Nifty 500 -5.6%

Latest mapped FPI equity flow was not positive. View sector evidence

Technical chart

PCBLD candles · FIT view+7.3%
Latest close ₹302.75 on 2026-10-19
Bar
-2.5%
RSI
34
MACD hist
-2.63
52W pos
51%
Visible chart range
Candle interval
2026-10-19O ₹310.50H ₹310.50L ₹301.55C ₹302.75Vol 4.4L sh
₹257.29₹287.86₹318.43₹348.99₹379.5652H₹302.752026-032026-06VolRSIMACD2026-042026-062026-082026-092026-11
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal
Market context

Relative performance and chart statistics

Adjusted completed-session prices, rebased to 100

PCBLNifty ChemicalsNifty 500
-11%-2%+6%+14%20 Jul1 Sept19 Oct19 Oct 2026PCBL -7.0%Nifty Chemicals -8.5%Nifty 500 -5.6%
PCBL
-7.0%
Nifty 500
-5.6%
Nifty Chemicals
-8.5%
Vs Nifty 500
-1.4 pp
Chart stats
19 Oct 2026
From 52W high
-22.5%
₹390.8
52W range position
46%
₹226.5 - ₹390.8
ATR (14)
3.2%
₹9.6
Volume vs 20D
0.47x
Latest completed session
Avg traded value
₹29.9 Cr
20-session average
20D price channel
₹301.6 - ₹356
23.6% annualized volatility
Research snapshot

What the evidence says now

Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend is neutral, and recent execution is weak.

Suggested next step
Check latest quarters
Result consistency is weak; verify whether the thesis is improving or deteriorating.
U-Score
Legacy · OVERVALUED
28

Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.

Latest result
Excellent
100

Revenue +17.0% · PAT +64.9% YoY

Technical
Neutral
50

Price trend and sector-relative-strength timing.

Valuation
Legacy model
-906.4%

Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.

Trust
Limited evidence
57

Financial-only signal; management claim evidence is not sufficient yet.

Financials

Fundamentals, quarterly history, margins, returns and balance-sheet evidence

Latest result

Quarter ended 30 Jun 2026

Excellent · 100/100

Rev +17% YoY · PAT +65% YoY · margin expansion · +20% QoQ · operating leverage

Filed 29 Jul 2026
Open results browser →
MetricThis quarterYoYQoQ
Revenue₹2,473 Cr+17.0%+19.7%
EBITDA₹396 Cr+24.1%+63.0%
Operating margin16.0%+100 bps+400 bps
PAT₹155 Cr+64.9%+287.5%
PAT margin6.3%+182 bps+433 bps

NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.

Fundamentals

Valuation

P/E
45.00
P/B
2.97
EV/EBITDA
11.24
Market Cap
11912.00Cr

Profitability

ROE
5.56%
ROCE
7.75%
ROA
2.29%
Dividend Y
1.90%

Growth (CAGR)

Revenue 5Y
25.00%
EPS 5Y
-7.00%
Revenue 3Y
12.00%
EPS 3Y
-21.00%

Balance Sheet

Debt/Equity
1.25
Interest Coverage
2.78×
Altman Z
2.68
Book Value
102.00

Cash Flow

FCF Yield
7.56%
FCF Positive Y
8/5
OCF
1576.00 Cr
EPS TTM
6.64

Shareholding

Promoter Hold
53.38%
Promoter Pledge
0.00%
Momentum 52W
52%

Financial History

Updated 20/10/2026

Revenue

₹ Cr
Latest: 5,777+3.6% vs prev
05905Mar 2017: 2,558Mar 2018: 3,529Mar 2019: 3,244Mar 2020: 2,660Mar 2021: 4,446Mar 2022: 5,874Mar 2023: 5,674Mar 2024: 5,905Mar 2025: 5,576Mar 2026: 5,777FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Net Profit

₹ Cr
Latest: 236-47.7% vs prev
0533.0Mar 2017: 70.0Mar 2018: 230Mar 2019: 389Mar 2020: 283Mar 2021: 312Mar 2022: 427Mar 2023: 444Mar 2024: 533Mar 2025: 451Mar 2026: 236FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Return on Equity

%
Latest: 5.8-51.6% vs prev
023.6Mar 2017: 6.2%Mar 2018: 16.8%Mar 2019: 23.6%Mar 2020: 16.7%Mar 2021: 16.2%Mar 2022: 16.4%Mar 2023: 15.7%Mar 2024: 16.3%Mar 2025: 12.1%Mar 2026: 5.8%FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Technicals

Trend interpretation, Stage 2, relative strength, volume and indicator evidence

Daily technical trend read

Bearish setup

Trend is weak — long-term uptrend intact. RSI 34.

  • Price above SMA200 (long-term uptrend) but mid-term MAs not aligned.
  • SMA20 roughly flat — short-term momentum stalled.
  • RSI(14) at 34 — falling, no extreme reading.
  • MACD below signal, histogram expanding negatively — bearish momentum building.
  • 19% off 52W high · 34% above 52W low.

Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.

Nifty 500 leadership

Relative Strength & Trend Stage

48
RS percentile
Stage 1 Base / Transition
1M return
-10.1%
3M return
-7.0%
6M return
+4.4%
1Y return
-17.1%
RS 1D
-2
RS 20D
-4
Sector rank
#13
Industry rank
-
Stage evidence
  • Price is within 0.5% of the 30-week proxy.
  • The 30-week proxy changed +2.0% over 20 sessions.
  • The moving-average structure does not confirm Stage 2 or Stage 4.
50-DMA
price below
200-DMA
price above
Sector
neutral
Industry
unranked
Relative-strength line vs Nifty 500 (base 100)
262 observations
19 Oct 2026Value 83.18-1.11%
65758494103Sept 25Feb 26Jun 26Oct 2683
RS vs Nifty 50083

Valuation & peers

U-Score 28 · legacy U-Score band OVERVALUED · valuation evidence and comparable companies

28U-SCORE
OVERVALUED

Fundamental score breakdown

U band · OVERVALUED
Valuation2/30
Growth8/25
Quality0/20
Balance Sheet5/15
Cash Flow10/10
Piotroski
5/9 (+3)
Penalties
0
Raw sum
28

Why this score?

Top U-Score contributors and drags from the latest stored fundamentals.

28/100 · legacy band OVERVALUED

Positive drivers

  • FCF yield is supportive at 7.6%.
  • Cash flow contributes 10/10 to the score.
  • Balance sheet contributes 5/15 to the score.

Main drags

  • Fair-value margin of safety is negative at -906.4%.
  • Quality is weaker at 0/20; verify the latest quarterly trend.
  • Valuation is weaker at 2/30; verify the latest quarterly trend.
Sector valuation model

Cyclical valuation: normalized earnings, not just trailing PE

Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.

Cyclical normalized
Primary lens
Mid-cycle PE/EV/EBITDA using multi-year average margins or earnings.
Secondary checks
Current margin versus 5-year average, balance sheet strength, commodity cycle.
Main risk check
A low trailing PE may mean peak-cycle earnings, not true cheapness.
PE
45.0
PB
3.0
EV/EBITDA
11.2
ROE
5.6%
ROCE
7.8%
FCF Yield
7.6%
Debt/Equity
1.3
MoS
-906.4%
Cyclical/value-trap warning
This sector can look cheap when profits are temporarily high. Check mid-cycle margins/earnings before relying on trailing PE. Debt/equity is 1.3, so downturn resilience matters.
Score movement

Stored run vs live recompute

This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.

Stored run: 20 Oct 2026
v4.3-runtime-valuation
Final score
28
Previous: 28
Legacy U-Score band
OVERVALUED
Previous: OVERVALUED
Margin of safety
-906.4%
Previous: -906.4%

Score history

12 stored score snapshots. Latest stored move: +1 points.

20 Oct 2026
v4.3-runtime-valuation
27
27
27
27
27
27
27
27
27
27
27
28

Factor attribution

No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.

Modelled fair value

Graham Number
₹123.45
-145.2% MoS
Growth-justified P/E
4.5
Growth-justified Value
₹30.08
-906.4% MoS
PEG
—

Comparable companies

Peers

Business-comparable peers in Chemicals — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.

Compare all ↗
Ticker
Name
Why peer
Score
PE
ROE
MoS
Verdict
SUMICHEM
Large
Sumitomo Chemical India Limited
Fertilizers & Agrochemicals
match 164
44
35.3
16.2%
-73%
WATCHLIST
SUDARSCHEM
Micro
Sudarshan Chemical Industries Limited
Fertilizers & Agrochemicals
match 163
24
89.6
0.5%
-8507%
OVERVALUED
KANSAINER
Micro
Kansai Nerolac Paints Limited
Fertilizers & Agrochemicals
match 163
38
22.5
8.8%
-176%
WATCHLIST
PRIVISCL
Micro
Privi Speciality Chemicals Limited
Fertilizers & Agrochemicals
match 162
66
38.0
26.0%
+18%
UNDERVALUED
NEOGEN
Micro
Neogen Chemicals Limited
Fertilizers & Agrochemicals
match 161
9
216.0
3.6%
-2868%
OVERVALUED

Business, management & trust

Growth engines, risks, management commitments and evidence-backed delivery

Business and thesis

Where growth can come from, and what can break the case

Thesis under stressReviewed 2026-06-03T18:23:30.168Z
Management commentary snapshot

Q4 FY26 Carbon Black Volumes Up YoY, But Margins Pressured by West Asia Conflict & Input Costs; Aquapharm Faces Headwinds.

The company navigated significant Q4 FY26 headwinds from the West Asia conflict, crude volatility, and logistics costs, impacting margins and Aquapharm's performance. However, management highlights clear recovery signals, including US tariff rationalization, India-EU FTA, customer restocking, and cost initiatives, projecting double-digit EBITDA growth for FY27.

Growth engines

Specialty Carbon Black

Specialty sales volumes grew by 26% YoY to 19,386 tons in Q4 FY26. Management is selectively increasing focus and resource reallocation in this segment.

Battery Chemicals (Nanovace)

Pilot plant at Palej is fully equipped and ready for commissioning within weeks. Engagement with large battery manufacturers is underway to validate product properties.

Export Market Expansion

India-EU FTA opens duty-free access to 1.8 million tons carbon black market. Recent U.S. tariff reduction restores cost advantage for Indian exports, seeing good traction from US customers.

Cost Reduction Initiatives

Program is progressing well, on track to unlock over INR 200-250 crores of savings over the next 4-6 quarters through yield improvement, throughput enhancement, and feedstock diversification.

Capacity and execution

Carbon Black Capacity

Added 90,000 tons of carbon black capacity (Brownfield expansion at Tamil Nadu), bringing total installed capacity to 880,000 tons per annum.

Superconductive Specialty Black Line

1,000 MTPA line at Palej, Gujarat, is mechanically ready for commissioning, but delayed due to gas shortage.

Specialty Black Line (Mudra)

20,000 tons line in Mudra is ready and will be commissioned in the next few weeks.

Aquapharm Capacity

Successfully expanded capacity from 130,000 tons to 167,000 tons during the year.

Tailwinds

Industry Recovery Signals

Broad industry dynamics show clear signs of recovery; spreads appear to have found a floor, and exit quarter momentum has turned positive.

Favorable Trade Policies

Recent rationalization of U.S. tariffs restored a meaningful cost advantage for Indian exports. India-EU FTA opens duty-free access to a significant carbon black market.

Customer Inventory Restocking

Customers are shifting from just-in-time to a 'just-in-case' approach, building strategic inventory buffers, which is translating into incremental demand.

Indian Tyre Sector Growth

The Indian tyre sector in FY27 is poised for robust, high single-digit growth, supported by high vehicle usage and aging commercial vehicle fleet.

Headwinds

West Asia Conflict Impact

Escalation of West Asia conflict created significant disruptions, massive increases in logistics cost, cost of feedstock, and availability of ships.

Raw Material Price Volatility

Raw material prices (linked to crude) rose sharply; Brent started at $60, ended March at $100, and is hovering close to $120 per barrel.

Contractual Lag Effect

Formula-based contracts with tyre majors carry an inherent quarterly lag effect, meaning the full impact of cost pass-through will reflect in Q2 FY27.

Aquapharm Raw Material & Logistics

Aquapharm faced 25-30% rise in raw material prices (yellow phosphorus, acrylic acid, malic acid), increased lead times, and freight rates due to West Asia conflict.

Risk radar

Geopolitical Instability

Ongoing West Asia conflict continues to pose risks to global supply chains, logistics, and raw material costs, impacting profitability.

Crude Price Volatility

Raw material prices are directly linked to crude, and continued high volatility can exert significant pressure on margins.

Domestic Overcapacity

Surplus domestic capacity in the carbon black industry persisted through Q4 FY26, potentially limiting pricing power.

New Product Qualification

Battery chemicals (Nanovace) require a validation period of a few months post-commissioning before capacity ramp-up begins.

Management accountability

What management said, and what results must prove

Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.

Analyst reading lens
Compare BOTH

YoY comparison is relevant for assessing overall growth and the impact of annual trends. QoQ is crucial for understanding sequential momentum, especially given the stated lag effect of cost pass-through in contracts and the expected recovery consolidation over the next 2-3 quarters.

Sector KPIs management disclosed

Carbon Black Sales Volume (Q4 FY26)

Consolidated sales volume increased by 8% YoY to 161,865 MT. Domestic sales volume grew by 21% YoY to 105,055 tons, while international sales volume decreased by 10% to 56,800 tons.

Carbon Black Sales Volume (FY26)

Sales volume for carbon black decreased 4% YoY to 618,956 metric tons in FY26 (vs 596,262 metric tons in FY25).

Consolidated EBITDA (Q4 FY26)

Consolidated EBITDA were INR 248 crores.

Consolidated EBITDA (FY26)

Consolidated EBITDA for FY26 stood at INR 1,081 crores as against INR 1,384 crores in FY25.

Management forward view

FY27 Outlook & Growth

Confident of delivering double-digit EBITDA growth in FY27, fueled by volume momentum, leaner cost structure, and better pricing realization.

Capital Allocation

Maintaining capital discipline with investment priorities towards specialty carbon black, battery chemicals, and other value-added segments.

Aquapharm Profitability Target

Goal remains to reach INR 75 crores per quarter EBITDA run rate for Aquapharm over the next 2-3 quarters.

Long-Term EBITDA Guidance

The long-term fundamentals remain intact, and the INR 40 billion EBITDA guidance by 2030 remains on track.

Thesis monitor

Numbers and claims to verify in the next filings

CheckpointCurrent evidenceWhat to verify next
Carbon Black EBITDA per tonQ4 FY26 EBITDA per ton not explicitly stated, but management noted it did not improve much QoQ.Strong double-digit increase in EBITDA per ton for FY27, driven by pricing, product mix, and cost initiatives.
Aquapharm Quarterly EBITDAINR 29 crores in Q4 FY26.Achievement of INR 75 crores per quarter EBITDA run rate within the next 2-3 quarters.
Nanovace (Battery Chemicals) ProgressPilot plant ready for commissioning; product validation with large battery manufacturers underway.Successful product qualification and commencement of commercial volumes, expected in FY28.
Cost Savings RealizationProgram progressing well.Realization of INR 200-250 crores of savings over the next 4-6 quarters from yield, throughput, and feedstock diversification.

Verification checkpoints are IndiaPulse research interpretation, not investment advice.

Trust Score
57Limited evidence · low confidenceTrust Lite

Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.

Limited evidence: Claim history is still being built. It ranks around the 20th percentile of the scored universe and 15th percentile within Chemicals. Main check: financial discipline is weak at 18/100.

This is a financial-behaviour screen, not a claim-tested management reliability verdict.

Computed 20 Oct 2026
management-trust-v1
77 docs text-extracted · 14 concalls text-extracted
Score band
Limited evidence

Financial behaviour is scored, but management claims do not yet have enough outcome checks.

Relative rank
20th percentile

overall median 67 · Chemicals: 15th pctile, median 73 · Large: 11th pctile, median 73

Evidence depth
Financial-only

77 documents have extracted text, but claim history is not strong enough yet.

Claim delivery
Outcome history still building

0 claims extracted · No contradicted claim yet

How to read this Trust Score

Limited evidence · low confidence
What it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Needs extra due diligence; demand valuation comfort and recent improvement.

Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.

Forensic breakdown

Read low sub-scores as due-diligence warnings, not automatic sell signals.

Promoter
78
strong · holding, pledge, alignment
Cash flow
89
strong · profit to cash conversion
Balance sheet
53
watch · leverage and solvency
Discipline
18
weak · capital discipline
Results
35
weak · quarterly consistency

Trust positives

  • ▸Promoter pledge is zero.
  • ▸FCF yield is 7.6%.
  • ▸8 years of positive FCF.
  • ▸OPM spread across recent quarters is 5%.

Trust risks

  • ▸3 latest quarters had PAT decline worse than 25% YoY.
  • ▸Debt/equity is 1.25.
  • ▸ROCE is low at 7.8%.
  • ▸ROE is low at 5.6%.

Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.

Important announcements & filings

Latest exchange and company disclosures found within the past two years.

12 shown
AnnouncementSep 2026

Sep 2026 · Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 18 Sep - PCBL Chemical will participate in PL Capital Investor Conference on 29 September 2026 in Mumbai.

Source: Bse

Open source ↗
Investor presentationAug 2026

Aug 2026 · PPT

Source: Bse

Open source ↗
Concall transcriptAug 2026

Aug 2026 · Transcript

Source: Bse

Open source ↗
AnnouncementAug 2026

Aug 2026 · Announcement under Regulation 30 (LODR)-Change in Management 21 Aug - Mr. Rohit Maindwal appointed Chief & Executive Director, Specialty Blacks, effective 20 August 2026.

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Newspaper Publication 26 Aug - Post Dispatch Newspaper Advertisement- Disclosure under Regulation 30 and Regulation 47 of the SEBI Listing Regulations

Source: Bse

Open source ↗
Credit ratingJul 2026

Jul 2026 · Announcement under Regulation 30 (LODR)-Credit Rating 7 Jul - CARE reaffirmed PCBL Chemical's bank facility ratings: AA Negative and A1+ on July 6, 2026.

Source: Bse

Open source ↗
AnnouncementJun 2026

Jun 2026 · Announcement under Regulation 30 (LODR)-Newspaper Publication 31 Jul - Newspaper Publication of Unaudited Financial Results for the Quarter ended 30th June, 2026 and Interim Dividend

Source: Bse

Open source ↗
AnnouncementJun 2026

Jun 2026 · Announcement under Regulation 30 (LODR)-Change in Management 9 Jun - Mr. Vaneet Kumar appointed Chief-Batteries and Executive Director effective 9 June 2026.

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Newspaper Publication 10 Jun - Special Window for Transfer and Dematerialization of Physical Securities

Source: Bse

Open source ↗
Concall transcriptMay 2026

May 2026 · Transcript

Source: Bse

Open source ↗
Investor presentationMay 2026

May 2026 · PPT

Source: Company Ir

Open source ↗
AnnouncementMay 2026

May 2026 · Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 21 May - PCBL Chemical will attend investor conferences on 28 May 2026 and 9 June 2026 in Mumbai.

Source: Bse

Open source ↗
Verify on:NSE India ↗
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.